The identification of a new role for LEKTI in the skin: The use of protein 'bait' arrays to detect defective trafficking of dermcidin in the skin of patients with Netherton syndrome

Journal of Proteomics
Kate BennettKevin Mills

Abstract

Lympho-Epithelial Kazal-Type-related Inhibitor (LEKTI) has been demonstrated to be an inhibitor of various kallikreins and is thought to play a role in the regulation of skin desquamation. In order to identify and investigate the potential of LEKTI to interact with other proteins, a method was developed using immobilised proteins onto arrays and nanoUPLC/MALDI-TOF MS. Using various domains of LEKTI, we demonstrated that these domains bound a number of kallikreins (5, 13 and 14) to varied extents on the array surface. Inhibitory assays confirmed that binding on the protein array surface corresponded directly to levels of inhibition. The method was then tested using skin epidermal extracts. All forms of rLEKTI with the exception of rLEKTI 12-15, demonstrated the binding of several potential candidate proteins. Surprisingly, the major binding partners of LEKTI were found to be the antimicrobial peptide dermcidin and the serine protease cathepsin G and no kallikreins. Using confocal microscopy and Netherton syndrome skin sections, we confirmed the co-localisation of LEKTI with dermcidin and demonstrated altered trafficking of dermcidin in these patients. This potential new role for LEKTI as a multifunctional protein in the protecti...Continue Reading

References

Nov 15, 1996·Biochimica Et Biophysica Acta·S S TwiningJ E Moulder
Nov 6, 2001·Nature Immunology·B SchittekC Garbe
Oct 16, 2002·Journal of Immunological Methods·Thomas FladHubert Kalbacher
Apr 22, 2005·Biological Chemistry·Loyse M FelberDavid Deperthes
Nov 26, 2005·The British Journal of Dermatology·T EgelrudH J Mägert
Dec 24, 2005·The Journal of Investigative Dermatology·Alessandro Tartaglia-PolciniMarina D'Alessio
Apr 8, 2006·The Journal of Investigative Dermatology·Jean-Pierre HachemPeter M Elias
May 23, 2007·Nature Cell Biology·Geertrui DeneckerWim Declercq
Feb 6, 2008·The Journal of Cell Biology·Geertrui DeneckerWim Declercq
Jun 16, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·D RoedlM Braun-Falco
Nov 17, 2009·Molecular Immunology·Timo BursterElizabeth D Mellins
Sep 30, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wei-Li DiWaseem Qasim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.